C-terminal mini-PEGylation of a marine peptide N6 had potent antibacterial and anti-inflammatory properties against Escherichia coli and Salmonella strains in vitro and in vivo

[1]  B. Palaniappan,et al.  Antibody therapy against antibiotic-resistant diarrheagenic Escherichia coli: a systematic review. , 2021, Immunotherapy.

[2]  Amy K. Cain,et al.  An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria , 2020, Nature Communications.

[3]  H. Fan,et al.  Therapeutic potential of a designed CSαβ peptide ID13 in Staphylococcus aureus-induced endometritis of mice , 2020, Applied Microbiology and Biotechnology.

[4]  B. Lazzaro,et al.  Antimicrobial peptides: Application informed by evolution , 2020, Science.

[5]  Xuehui Liu,et al.  Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli , 2020, Communications Biology.

[6]  R. Mikut,et al.  The effect of lipidation and glycosylation on short cationic antimicrobial peptides. , 2020, Biochimica et biophysica acta. Biomembranes.

[7]  A. Shan,et al.  Multiple Strategy Optimization of Specifically Targeted Antimicrobial Peptide Based on Structure-Activity Relationships to Enhance Bactericidal Efficiency. , 2020, ACS biomaterials science & engineering.

[8]  D. Teng,et al.  A new high-yielding antimicrobial peptide NZX and its antibacterial activity against Staphylococcus hyicus in vitro/vivo , 2020, Applied Microbiology and Biotechnology.

[9]  P. Dai,et al.  Self-made Salmonella Pullorum agglutination antigen development and its potential practical application , 2019, Poultry science.

[10]  Zhi-Ye Zhang,et al.  Antimicrobial peptides: new hope in the war against multidrug resistance , 2019, Zoological research.

[11]  Quan-yong He,et al.  The antimicrobial peptides and their potential clinical applications. , 2019, American journal of translational research.

[12]  H. Bax,et al.  Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus , 2019, The Journal of antimicrobial chemotherapy.

[13]  D. Teng,et al.  A recombinant fungal defensin-like peptide-P2 combats multidrug-resistant Staphylococcus aureus and biofilms , 2019, Applied Microbiology and Biotechnology.

[14]  R. Hancock,et al.  Aurein-Derived Antimicrobial Peptides Formulated with Pegylated Phospholipid Micelles to Target Methicillin-Resistant Staphylococcus aureus Skin Infections. , 2019, ACS infectious diseases.

[15]  Xiangdong Gao,et al.  C-terminal site-specific PEGylated Exendin-4 analog: A long-acting glucagon like Peptide-1 receptor agonist, on glycemic control and beta cell function in diabetic db/db mice. , 2018, Journal of pharmacological sciences.

[16]  R. Mirnejad,et al.  Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. , 2018, Microbial drug resistance.

[17]  J. Lambris,et al.  New Analogs of the Complement C3 Inhibitor Compstatin with Increased Solubility and Improved Pharmacokinetic Profile. , 2018, Journal of medicinal chemistry.

[18]  K. Baek,et al.  Tryptophan-Rich and Proline-Rich Antimicrobial Peptides , 2018, Molecules.

[19]  D. Teng,et al.  Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo , 2018, Scientific Reports.

[20]  Jayachandran N. Kizhakkedathu,et al.  Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo , 2018, Biomolecules.

[21]  Publisher's Note , 2018, Anaesthesia.

[22]  S. Deng,et al.  Protease Hydrolysates of Filefish (Thamnaconus modestus) Byproducts Effectively Inhibit Foodborne Pathogens. , 2017, Foodborne pathogens and disease.

[23]  D. Teng,et al.  Antibacterial and immunomodulatory activities of insect defensins-DLP2 and DLP4 against multidrug-resistant Staphylococcus aureus , 2017, Scientific Reports.

[24]  Xuehui Liu,et al.  Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis , 2017, Scientific Reports.

[25]  J. Leroux,et al.  Releasable and traceless PEGylation of arginine-rich antimicrobial peptides† †Electronic supplementary information (ESI) available: Experimental procedures, synthesis and characterization of rPEGylation reagents and peptide–PEG conjugates, kinetic studies of PEGylation and dePEGylation (HPLC) and co , 2017, Chemical science.

[26]  R. Isaacson,et al.  Salmonella in Swine: Microbiota Interactions. , 2017, Annual review of animal biosciences.

[27]  Shamala Devi Sekaran,et al.  Intracellular Targeting Mechanisms by Antimicrobial Peptides , 2017, Antimicrobial Agents and Chemotherapy.

[28]  B. Pang,et al.  Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhea in Beijing, China (2010–2014) , 2016, Gut Pathogens.

[29]  Ranjita Shegokar,et al.  Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications , 2016, Expert opinion on drug delivery.

[30]  A. Pini,et al.  In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate , 2016, Scientific Reports.

[31]  F. S. Hsiao,et al.  The proteome targets of intracellular targeting antimicrobial peptides , 2016, Proteomics.

[32]  D. Teng,et al.  Mechanism of action of a novel recombinant peptide, MP1102, against Clostridium perfringens type C , 2016, Applied Microbiology and Biotechnology.

[33]  Jing Tang,et al.  A three-year survey of the antimicrobial resistance of microorganisms at a Chinese hospital , 2016, Experimental and therapeutic medicine.

[34]  D. G. Lee,et al.  A novel antimicrobial peptide, scolopendin, from Scolopendra subspinipes mutilans and its microbicidal mechanism. , 2015, Biochimie.

[35]  M. Benincasa,et al.  PEGylation of the peptide Bac7(1-35) reduces renal clearance while retaining antibacterial activity and bacterial cell penetration capacity. , 2015, European journal of medicinal chemistry.

[36]  S. Straus,et al.  Conjugation of aurein 2.2 to HPG yields an antimicrobial with better properties. , 2015, Biomacromolecules.

[37]  D. Teng,et al.  GAP-initiated constitutive expression of a novel plectasin-derived peptide MP1106 by Pichia pastoris and its activity against Streptococcus suis , 2015 .

[38]  D. Teng,et al.  A dual mechanism involved in membrane and nucleic acid disruption of AvBD103b, a new avian defensin from the king penguin, against Salmonella enteritidis CVCC3377 , 2014, Applied Microbiology and Biotechnology.

[39]  A. Schmidtchen,et al.  Effects of PEGylation on membrane and lipopolysaccharide interactions of host defense peptides. , 2014, Biomacromolecules.

[40]  A. Pini,et al.  Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase , 2014, Amino Acids.

[41]  E. Palombo,et al.  The Antimicrobial Domains of Wheat Puroindolines Are Cell-Penetrating Peptides with Possible Intracellular Mechanisms of Action , 2013, PloS one.

[42]  B. Finlay,et al.  Recent Advances in Understanding Enteric Pathogenic Escherichia coli , 2013, Clinical Microbiology Reviews.

[43]  Peng Zhan,et al.  Current drug research on PEGylation with small molecular agents , 2013 .

[44]  K. Beck,et al.  Pegylation of Antimicrobial Peptides Maintains the Active Peptide Conformation, Model Membrane Interactions, and Antimicrobial Activity while Improving Lung Tissue Biocompatibility following Airway Delivery , 2012, Antimicrobial Agents and Chemotherapy.

[45]  Christopher M Yip,et al.  Roles of Hydrophobicity and Charge Distribution of Cationic Antimicrobial Peptides in Peptide-Membrane Interactions* , 2012, The Journal of Biological Chemistry.

[46]  T. Palm,et al.  The effect of PEGylation on the stability of small therapeutic proteins , 2011, Pharmaceutical development and technology.

[47]  M. Benincasa,et al.  The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection , 2010, BMC Microbiology.

[48]  Analette I. Lopez,et al.  Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers. , 2009, Molecular bioSystems.

[49]  F. Lozano,et al.  [Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice]. , 2009, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[50]  B. Han,et al.  Modification of antimicrobial peptide with low molar mass poly(ethylene glycol). , 2008, Journal of biochemistry.

[51]  Y. Nakata,et al.  Decoralin, a novel linear cationic α-helical peptide from the venom of the solitary eumenine wasp Oreumenes decoratus , 2007, Peptides.

[52]  Byung Kook Lee,et al.  Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity. , 2007, Bioconjugate chemistry.

[53]  M. Nishida,et al.  Action mechanism of PEGylated magainin 2 analogue peptide. , 2007, Biochimica et biophysica acta.

[54]  M. Nishida,et al.  Action mechanism of tachyplesin I and effects of PEGylation. , 2007, Biochimica et biophysica acta.

[55]  B. Coburn,et al.  Salmonella, the host and disease: a brief review , 2007, Immunology and cell biology.

[56]  K. Preissner,et al.  Microbial Metalloproteinases Mediate Sensing of Invading Pathogens and Activate Innate Immune Responses in the Lepidopteran Model Host Galleria mellonella , 2006, Infection and Immunity.

[57]  H. Wennemers,et al.  Peptide-polyethylene glycol conjugates: synthesis and properties of peptides bearing a C-terminal polyethylene glycol chain. , 2006, Bioorganic & medicinal chemistry.

[58]  S. Oh,et al.  Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[59]  A. Bernkop‐Schnürch,et al.  Strategies to improve plasma half life time of peptide and protein drugs , 2006, Amino Acids.

[60]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[61]  K. Lumb,et al.  Contribution of site-specific PEGylation to the dipeptidyl peptidase IV stability of glucose-dependent insulinotropic polypeptide. , 2005, Bioorganic & medicinal chemistry letters.

[62]  Y. Byun,et al.  Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1. , 2005, Bioconjugate chemistry.

[63]  E. Chaikof,et al.  C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity. , 2004, Bioconjugate chemistry.

[64]  A. Bernkop‐Schnürch,et al.  Development and in vivo evaluation of an oral insulin-PEG delivery system. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[65]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[66]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[67]  M. Treuheit,et al.  Mono-N-terminal poly(ethylene glycol)-protein conjugates. , 2002, Advanced drug delivery reviews.

[68]  M. Bentley,et al.  Chemistry for peptide and protein PEGylation. , 2002, Advanced drug delivery reviews.

[69]  J. L. Ding,et al.  Definition of endotoxin binding sites in horseshoe crab Factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  J. Hurley,et al.  Antibiotic-induced release of endotoxin: a reappraisal. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  F. Veronese,et al.  The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.

[72]  Sanjay K. Jain,et al.  PEGylation: an approach for drug delivery. A review. , 2008, Critical reviews in therapeutic drug carrier systems.

[73]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[74]  S. Chae,et al.  Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability. , 2007, Biochemical pharmacology.

[75]  F. Veronese,et al.  PEGylation of the antimicrobial peptide nisin A: problems and perspectives. , 2003, Farmaco.

[76]  G. Molineux.  Pegylation: engineering improved pharmaceuticals for enhanced therapy. , 2002, Cancer treatment reviews.

[77]  P. Caliceti,et al.  A branched monomethoxypoly(ethylene glycol) for protein modification. , 1995, Bioconjugate chemistry.